David Thomas

36PUBLICATIONS

292CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cancer diagnosisMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (36)

Sort by Publication Date:

|Jun 16, 2026

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|Apr 24, 2026

Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.

|Apr 23, 2026

Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

|Mar 27, 2026

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature.

Tanya M Dwarte, Rozanna Alli, Shweta Srinivasa

|Feb 13, 2026

Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation.

Benjamin Koh, Subotheni Thavaneswaran, Frank Lin

|Jan 09, 2026

TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

Pageof 6

Frequent Collaborators

16 joint publications

Mandy L Ballinger

10 joint publications

Megan C Best

10 joint publications

Phyllis Butow

Christine Napier

Nicole Bartley

Ainsley J Newson

David Goldstein

Ilona Juraskova

Bettina Meiser

Jacqueline Savard

Frequent Collaborators

16 joint publications

Mandy L Ballinger

10 joint publications

Megan C Best

10 joint publications

Phyllis Butow

9 joint publications

Christine Napier